Меню
Страницы
Статья
Screening
Screening examinations for the 9 months of 2026 Kyzylorda Region
The target for 2026 was 461,732 people. During the first 9 months of 2026, 395,660 people (85.7%) were examined. The number of detected cases of disease was 25,433 (6.4%). All 25,433 (100%) were placed under dispensary observation.
Screening for circulatory system diseases covered 65,071 (90.8%) of the 71,691 targeted residents. Cases detected: 2,644 (4.1%). All 2,644 (100%) were placed under dispensary observation.
Screening for diabetes mellitus covered 72,530 (101.2%) of the 71,691 targeted residents. Cases detected: 1,256 (1.7%). All 1,256 (100%) were placed under dispensary observation.
Screening for glaucoma covered 75,181 (101.2%) people out of the target of 71,691. Cases detected: 217 (0.3%). All 217 (100%) were placed under dispensary observation.
Breast cancer screening: 55,610 people targeted; 49,145 (88.4%) examined during the 9-month period. Cases detected: 15,183 (30.9%). All 15,183 (100%) were placed under dispensary observation. Cervical cancer: 39,151 cases planned, 35,435 completed (90.5%); 5,516 cases detected (15.6%); 5,516 placed under clinical monitoring (100%).
Colorectal cancer: 69,267 cases planned, 60,509 completed (87.4%); 177 cases detected (0.3%); 177 placed under clinical monitoring (100%).
Hepatitis B and C: 70,478 cases planned, 28,236 completed (40.1%); 66 cases detected (1.1%); 66 placed under clinical monitoring (100.0%).
Early detection of cerebrovascular diseases: 12,153 cases planned, 9,553 completed (78.6%); 374 cases detected (3.9%); 374 placed under clinical monitoring (100%).
Screening for the first six months of 2026 in Kyzylorda Region
461,732 people are planned for 2026. During the first six months of 2026, 307,903 (66.7%) were screened. The number of detected diseases was 19,473 (6.3%). 18,707 (96.1%) were registered for "D" status.
Screening for circulatory diseases covered 46,430 (64.8%) of the planned 71,691 residents. 1,815 (3.9%) were identified. Of these, 1,815 (100%) were registered for "D" status.
Screening for diabetes covered 56,900 (79.4%) of the planned 71,691 residents. 832 patients were identified (1.5%). Of these, 32 (3.8%) were enrolled in the "D" program.
60,803 (84.8%) people were covered for glaucoma, while 71,691 people were screened. 162 patients were identified (0.3%). Of these, 162 (100%) were enrolled in the "D" program.
The total number of breast cancer cases planned for the six months was 55,610; 37,696 (67.8%) were identified. 11,582 (30.7%) were enrolled in the "D" program. Cervical cancer cases totaled 39,151 planned, 29,255 completed (74.7%), 4,356 cases detected (14.9%), and 4,339 cases registered for "D" status (99.6%).
Colorectal cancer cases totaled 69,267 planned, 42,330 completed (61.1%), 158 cases detected (0.4%), and 158 cases registered for "D" status (100%).
Hepatitis B and C cases totaled 70,478 planned, 28,236 completed (40.1%), 66 cases detected (0.23%), and 58 cases registered for "D" status (87.9%). In terms of early detection of cerebrovascular diseases, a total of 12,153 cases were planned, 6,253 (51.5%) were completed. 568 cases (9.1%) were detected, and 561 (98.8%) were registered as "D" cases.
Screening examination for 9 months of 2025
in Kyzylorda region
The planned population for 2025 is 487,897. During the first nine months of 2025, 331,972 (80.0%) were screened. The number of detected diseases was 22,641 (6.8%). 21,204 (93.7%) were registered for "D" status.
Screening for circulatory diseases covered 69,633 (97.1%) of the planned 71,730 residents. The number of detected cases was 2,742 (3.9%). Of these, 2,742 (100%) were registered for "D" status.
Screening for diabetes covered 76,733 (84.9%) of the planned 90,377 residents. The number of detected cases was 737 (1.0%). Of these, 737 (100%) were enrolled in the "D" program.
79,325 (84.2%) people were covered for glaucoma, and 94,249 people were screened. 276 patients (0.3%) were identified. Of these, 276 (100%) were enrolled in the "D" program.
The total number of breast cancer cases planned was 45,343; over the 9 months, 36,973 (81.5%) were identified. 11,503 (31.1%) were enrolled in the "D" program. Cervical cancer cases totaled 37,978 planned, 29,247 (77.0%) completed, 4,180 (14.3%) detected cases, and 4,179 (100%) included in the "D" list.
Colorectal cancer cases totaled 47,968 planned, 40,061 (83.5%) completed, 165 (0.4%) detected cases, and 165 (100%) included in the "D" list.
Hepatitis B and C cases totaled 71,580 planned, 47,538 (66.4%) completed, 454 (0.6%) detected cases, and 88 (19.4%) included in the "D" list.
Screening examination for 6 months of 2025
in Kyzylorda region
599,625 people are planned for 2025. For 6 months of 2025, 245,240 (40.9%) were examined. The number of identified diseases is 12,734 (5.2%). 12,592 (98.9%) were taken into "D" registration.
47,304 (43.5%) of the planned 108,837 residents were covered by screening examination for diseases of the circulatory system. 1,558 (3.3%) were identified. Of these, 1,558 (100%) were taken into "D" registration. Screening examination for diabetes mellitus covered 47,723 (43.5%) of the planned 128,603 residents. The number of identified patients is 454 (0.9%). Of these, 454 (100%) were taken into "D" registration.
For glaucoma, 50,676 people were screened, out of 132,688 (38.2%) people. The number of identified patients is 226 (0.4%). Of these, 226 (100%) were taken into "D" registration.
The number of planned cases of breast cancer is 45,343, for 6 months - 25,103 (55.4%). The number of identified diseases is 7,219 (28.8%). Of these, 7,219 (100%) were taken into "D" registration. Cervical cancer cases total planned - 37,979, completed - 20,476 (53.9%). Diseases identified - 2,831 (13.8%). Taken for "D" registration - 2,830 (100%).
Colon and rectal cancer cases total planned - 47,967. completed - 27,722 (51.5%). Diseases identified - 133 (0.5%). Taken for "D" registration - 133 (100%).
Hepatitis B and C cases total planned - 70,476. completed - 28,236 (40.0%). Diseases identified - 313 (1.1%). Taken for "D" registration - 60 (19.1%).
Screening examination for 3 months of 2025 in Kyzylorda region
Based on the order of the Acting Minister of Health of the Republic of Kazakhstan dated October 30, 2020, No. KR DSM-174/2020, "On approval of target groups of persons subject to screening studies, as well as the rules, volume, and frequency of these examinations," examinations of target groups are conducted in institutions providing primary health care. Screening examinations for these target groups are performed for seven conditions: diseases of the circulatory system, diabetes mellitus, glaucoma, breast cancer, cervical cancer, and colon and rectal cancer.
The planned number of people for 2025 is 599,625. In the first three months of 2025, 87,551 people were examined, which is 14.6% of the total. A total of 3,720 diseases were identified, representing 4.2%. Of these, 2,996 people, or 80.5%, were registered under "D." The screening for diseases of the circulatory system included 15,946 residents, or 14.7% of the planned 108,837. Among these, 542 patients were identified, which is 3.4%, and 435 of them, or 91.9%, were registered under "D." The diabetes screening covered 17,311 residents, or 13.5% of the planned 128,603. Here, 148 patients were identified, representing 0.9%, with 136 of them, or 91.9%, registered under "D." For glaucoma, 17,999 people were planned, and 45,343, or 13.6%, underwent screening. 81 patients were identified, which is 0.5%, and 48 of them, or 59.3%, were registered under "D." A total of 9,957 cases of breast cancer were planned, with 47,976, or 22.0%, completed in three months. Diseases were identified in 1,877 cases, or 18.9%, and 1,583 of these, or 84.3%, were registered under "D." For cervical cancer, 37,979 cases were planned, and 8,163, or 21.5%, were performed. Diseases were identified in 915 cases, or 11.2%. For colorectal cancer, 740 cases were planned out of a total of 47,967, with 5,876, or 12.3%, completed. 30 cases, or 0.5%, were identified. For hepatitis B and C, 29 cases were planned out of 70,476, with 12,299, or 17.4%, completed. 127 cases, or 1.0%, were identified, and 25 cases, or 19.6%, were taken into account.
Screening examination for 9 months of 2024 in Kyzylorda region
For 2024, 372 402 people are planned. For 9 months of 2024, 363 025 (97,5%) people were examined. The number of identified diseases is 15 937 (4,4%). Registered as “D” – 12 589 (79,0%).
Screening examinations for diseases of the circulatory system covered 78 390 (100,5%) of the planned 77 994 residents. Identified patients - 3 097 (4,0%). Of these, 2 888 (93,3%) were registered “D”.
Screening examinations for diabetes mellitus covered 87 955 (97,9%) of the planned 89,842 residents. Identified patients – 717 (0,8%). Of these, 717 (100,0%) were registered as “D”.
91 107 (97,6%) people were scheduled for glaucoma, 71,835 people (70.0%) were covered by screening examinations. Identified patients – 293 (0,3%). Of these, 293 (100,0%) were registered as “D”.
Total cases of breast cancer planned - 38,123, over 9 months - 36 051 (94,6%), diseases detected - 8 688 (24,1%), registered as "D" - 5 969 (68,7%).
A total of 28,406 cases of cervical cancer were planned, 27 989 (98,5%) were completed, 3 025 (10,8%) were detected, 2 605 (86,1%) were registered as “D”.
A total of 44,735 cases of colon and rectal cancer were planned, 41 533 (92,8%) were completed, 117 (0,3%) were detected, 117 (100,0%) were registered as “D”.
Screening examination for 6 months of 2024 in Kyzylorda region
For 2024, 372 402 people are planned. For 6 months of 2024, 291 101 (78.2%) people were examined. The number of identified diseases is 12 210 (4,2%). Registered as “D” – 8 293 (67,9%).
Screening examinations for diseases of the circulatory system covered 63 593 (81,5%) of the planned 77 994 residents. Identified patients - 2 047 (3,2%). Of these, 1 966 (96,0%) were registered “D”.
Screening examinations for diabetes mellitus covered 69,235 (77.1%) of the planned 89,842 residents. Identified patients – 520 (0.5%). Of these, 507 (97.5%) were registered as “D”.
93,302 people were scheduled for glaucoma, 71,835 people (70.0%) were covered by screening examinations. Identified patients – 248 (0.3%). Of these, 244 (98.4%) were registered as “D”.
Total cases of breast cancer planned - 38,123, over 6 months - 29,862 (78.3%), diseases detected - 6,731 (22.5%), registered as "D" - 3,677 (54.6%).
A total of 28,406 cases of cervical cancer were planned, 24,592 (86.6%) were completed, 2,539 (10.3%) were detected, 1,814 (71.4%) were registered as “D”.
A total of 44,735 cases of colon and rectal cancer were planned, 31,984 (71.5%) were completed, 125 (0.4%) were detected, 85 (68.0%) were registered as “D”.
Screening examination for first quarter of 2024 in Kyzylorda region
For 2024, 372 402 people are planned. For 3 months of 2024, 158 862 (42,7%) people were examined. The number of identified diseases is 5 674 (3,6%). Registered as “D” – 3 811 (67,2%).
Screening examinations for diseases of the circulatory system covered 32 254 (41,4%) of the planned 77 994 residents. Identified patients - 964 (3,0%). Of these, 848 (88,0%) were registered “D”.
93 302 people were scheduled for glaucoma, 40 399 people (43.3%) were covered by screening examinations. Identified patients – 162 (0.4%). Of these, 147 (90.7%) were registered “D”.
Screening examinations for diabetes mellitus covered 38 680 (43.1%) of the planned 89 842 residents. Identified patients – 251 (0.6%). Of these, “D” was taken into account - 200 (79.7%).
The total number of breast cancer cases planned is 38 123, over 3 months – 15 489 (40,6%), diseases detected – 2 888 (18,6%), registered as “D” – 1 649 (57,1%).
A total of 28 406 cases of cervical cancer were planned, 15 594 (54,9%) were completed, 1 370 (8,8%) were detected, 934 (68,2%). were registered as “D”.
A total of 44 735 cases of colon and rectal cancer were planned, 16 466 (36,8%), were completed, 39 (0,2%) were detected, 33 (84,6%) were registered as “D”.
Screening examination for 12 months of 2023 in Kyzylorda region
For 2023, 352 600 people are planned. 348 349 (98.8%) were examined in the 12 months of 2023. The number of diagnosed diseases is 13 764 (4.0%). 12 930 (93.6%) are on account D. Screening for diseases of the blood circulation system reached 71 822 (99.5%) from 72 199 planned residents. The number of identified patients is 3010 (4.2%). Of these, the «D» is taken into account – 2997 (99.6%).
87 984 people are planned for glaucoma, 87 703 people (99.7%) are covered by screening. 270 patients are identified (0.3%). Of these, recorded «D» is 263 (97.4%).
The screening for diabetes mellitus covers 84 569 (99.2%) of the planned 85274 residents. Revealed patients - 631 (0.7%). Of them, the «D» - 631 (100%).
The total number of cases of breast cancer is planned to be 37164; 34863 (93.8%) within 12 months, 7137 (20.5%) and 6503 (91.1%) registered for «D».
The total number of cases of cervical cancer is planned to be 26948, 26672 (99.0%) were performed, 2651 (9.9%) were detected, and 2481 (93.6%) were recorded for «D».
The number of cases of colon and rectal cancer is planned to be 43031 and 42720 (99.3%) were performed, 65 (0.2%) were detected, 55 (84.6%) were registered at «D».
Screening examination for 9 months of 2023
in Kyzylorda region
For 2023, 345,354 people are planned. For 9 months of 2023, 328,878 (95.2%) were examined. The number of identified diseases is 11,482 (3.5%). Registered as “D” – 7501 (65.3%).
Screening examinations for diseases of the circulatory system covered 68,385 (99.7%) of the planned 68,605 residents. Identified patients – 2,537 (3.7%). Of these, “D” was taken into account - 2,474 (97.5%).
86,351 people were scheduled for glaucoma, 82,926 people (96.0%) were covered by screening examinations. Identified patients – 260 (0.3%). Of these, 229 (88.1%) were registered “D”.
Screening examinations for diabetes mellitus covered 80,284 (96.4%) of the planned 83,239 residents. Identified patients – 535 (0.7%). Of these, “D” was taken into account - 502 (94%).
The total number of breast cancer cases planned is 37,121, over 9 months – 32,275 (86.9%), diseases detected – 5,869 (18.2%), registered as “D” – 3,177 (54.1%) .
A total of 26,940 cases of cervical cancer were planned, 25,113 (93.2%) were completed, 2,224 (8.9%) were detected, 1,080 (49%) were registered as “D”.
A total of 43,098 cases of colon and rectal cancer were planned, 39,895 (92.6%) were completed, 57 (0.1%) were detected, 39 (68.4%) were registered as “D”.
Screening examination for 3 months of 2023 in Kyzylorda region
345,354 people are planned for 2023. For 6 months of 2023, 265,088 (76.8%) were examined. The number of detected diseases is 8910 (3.4%). Taken on "D" account - 7741 (86.9%).
Screening examinations for diseases of the circulatory system covered 55,722 (81.2%) of the planned 68,605 residents. Identified patients - 2123 (3.8%). Of these, "D" - 1968 (92.7%) was taken into account.
86,351 people are scheduled for glaucoma, 67,283 people (77.9%) are covered by screening examination. Identified patients – 235 (0.3%). Of these, registered "D" - 182 (77.4%).
64,983 (78.1%) of the planned 83,239 residents were covered by the screening examination for diabetes mellitus. Identified patients - 429 (0.7%). Of these, "D" was taken into account - 397 (92.5%).
In total, 37,121 cases of breast cancer were planned, for 6 months - 26,053 (70.2%), diseases were detected - 4517 (17.3%), 4264 (94.4%) were taken into account.
In total, 26,940 cases of cervical cancer were planned, 20,696 (76.8%) were completed, diseases were detected - 1564 (7.6%), and 904 (57.8%) were registered for "D".
In total, 43,098 cases of colon and rectal cancer were planned, 30,351 (70.4%) were completed, 42 (0.2%) cases were detected, and 26 (61.9%) were registered.
Screening for 12 months of 2021
in Kyzylorda region
115,003 people are planned for 2021. During the 12 months of 2021, 113,052 (98%) were examined. The number of detected diseases is 9854 (8.7%). Taken on the "D" account - 5948 (60.4%).
The total number of cases of breast cancer is planned - 35,795, in 12 months – 40,622 (97%), diseases were detected – 6374 (15.7%), 3985 (62.5%) were taken into account.
The total number of cases of cervical cancer is planned - 34,332, 33,548 (97.7%) have been completed, 3432 (10.2%) diseases have been detected, 1916 (55.8%) have been registered.
The total number of cases of colon and rectal cancer is 38,797, 38,882 (100%) have been completed, 48 (0.1%) diseases have been detected, 47 (97.9%) have been registered.
Screening for 9 months of 2021 in the Kyzylorda region
For 2021, 115,003 people are planned. For 9 months of 2021, 102,236 (88.8%) were examined. The number of diagnosed diseases is 1,536 (1.5%). Taken on the "D" account for malignant neoplasms - 33 (0.05%).
The total number of cases of breast cancer is planned - 35 795, for 9 months - 35 795 (85.5%), diseases detected - 1205 (3.3%), registered on "D" for malignant neoplasms - 33 (0.09% ).
The total number of cases of cervical cancer is planned - 34,332, completed - 30,977 (90.2%), detected diseases - 291 (0.9%), registered for malignant neoplasms - 18 (0.05%).
The total number of cases of colon and rectal cancer is planned - 38 797, completed - 35 464 (91.4%), diseases detected - 40 (0.1%), taken on "D" records for malignant neoplasms - 7 (0.02% ).
Screening for 6 months of 2021 in the Kyzylorda region
For 2021, 115,003 people are planned. For 6 months of 2021, 76,044 (66.1%) were examined. The number of diagnosed diseases - 1,266 (1.6%). Taken on "D" records for malignant neoplasms - 37 (2.9%).
In total, 41,874 cases of breast cancer were planned, for 6 months - 28,215 (67.4%), diseases were detected - 3986 (3.5%), 19 (0.5%) were registered for malignant neoplasms. ).
The total number of cases of cervical cancer was planned - 34,332, completed - 23,236 (67.8%), diagnosed diseases - 243 (1.0%), registered for "D" malignant neoplasms - 12 (4.9%).
The total number of cases of colon and rectal cancer is planned - 38,797, completed - 24,550 (63.3%), diseases detected - 37 (0.1%), registered for malignant neoplasms - 6 (16.2%) ).
Screening for 2019 in the Kyzylorda region
For 2019, 298,261 people are planned. It was examined - 296960 (99.5%). The number of detected diseases is 14646 (4.9%). Taken for registration D - 13229 (90.3%).
The total circulatory system diseases planned - 36136, completed - 63136 (100%), the Number of identified diseases - 5586 (8.8), taken to "D" registration - 4733 (84.7%).
Diabetes mellitus was planned in total - 63136, completed - 63136 (100%), revealed diseases - 1132 (1.7%), and 897 (79.2%) were taken to “D”.
Glaucoma in total is planned - 63,340, completed - 63340 (100%), revealed diseases - 667 (1.0%), taken to “D” accounting - 650 (43.3%).
A total of 34797 cases of breast cancer were planned, 3499 were completed (97.9%), 4369 diseases were detected (12.8%), 4230 (96.8%) were taken to “D”. Revealed-63 cases of cancer.
A total of 36313 cases of cervical cancer were planned, 35628 were performed (98.1%), 2692 (7.5%) were detected, 2585 (96%) were taken to “D”. 25 cases of cancer have been identified.
Cases of colon and rectal cancer were planned in total - 37539, completed - 37539 (100%), detected diseases - 200 (0.5%), taken to “D” registration - 134 (67%). Identified 14 cases of cancer.